Polymedco CDP, LLC. Announces New Agreement with Veterans Administration for Colorectal Cancer Screening

Thursday, March 2, 2017 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

CORTLANDT MANOR, N.Y., March 2, 2017 /PRNewswire/ -- The Veterans Administration now has access to the most comprehensive

colorectal cancer screening tools available in the United States today.  Polymedco, U.S. distributor for OC-Light® S FIT manual fecal immunochemical test and Epi proColon® molecular blood test for colorectal cancer screening,
has been awarded a 5 year contract commencing March 1, 2017 for these items.  This is in addition to the existing contract for Polymedco's OC-Auto® automated FIT system, which is currently in place in over 100 VA facilities nationwide.    

Polymedco's FIT is recommended as a first screen by the United States Preventive Services Task Force and Epi proColon® is FDA approved for colorectal cancer screening for people who are unwilling or unable to be screened by recommended methods. 

"We are excited to continue our relationship with the Veterans Administration and pleased to be able to offer them our complete offering of colorectal cancer screening tools," stated Polymedco president Drew Cervasio.  Colorectal cancer is the second leading cause of cancer related deaths in the United States and the third most common type of cancer in both men and women.  Colorectal cancer has a 91% survival rate if caught in Stage I, but only an 11% survival rate if caught in Stage IV.  March is colorectal cancer awareness month.

The VA operates the nation's largest integrated healthcare system, with more than 1700 hospitals, clinics, community living centers, domiciliaries, readjustment counseling centers, and other facilities.  There are 9.5 million veterans nationwide, the majority of whom receive care through the Veterans Administration. 

Since 1980, Polymedco has evolved into a leading manufacturer, marketer, and distributor in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and POC devices that are specialized in chemistry, hematology and cancer screening. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC-Auto®, OC-Light® S and Epi proColon® product lines.

For More Information, please visit our website: http://www.polymedco.com or contact us at 800-431-2123 or [email protected].

Polymedco, Inc. 510 Furnace Dock Road Cortlandt Manor, NY  10567  USA Telephone: 800-431-2123 Facsimile: 914-739-5890

OC-Auto and OC-Light are registered trademarks of Polymedco CDP, LLC. Epi proColon is a registered trademark of Epigenomics AG.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/polymedco-cdp-llc-announces-new-agreement-with-veterans-administration-for-colorectal-cancer-screening-300416974.html

SOURCE Polymedco CDP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook